Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H ( (HK:1558) ) has issued an announcement.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. has announced the withdrawal of its H Shares from the Hong Kong Stock Exchange, effective from August 5, 2025. This move is part of a merger with Sunshine Lake Pharma Co., Ltd., where a share exchange will occur, allowing shareholders to exchange their H Shares for Offeror H Shares at a specified ratio. The delisting and share exchange are significant steps in the merger process, impacting the company’s market presence and shareholder structure.
The most recent analyst rating on (HK:1558) stock is a Buy with a HK$13.80 price target. To see the full list of analyst forecasts on YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H stock, see the HK:1558 Stock Forecast page.
More about YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
Average Trading Volume: 9,734,931
Technical Sentiment Signal: Buy
Current Market Cap: HK$12.65B
For an in-depth examination of 1558 stock, go to TipRanks’ Overview page.